About us

Careers

Scroll To Explore

Join us

 

We are committed to discovering and developing breakthrough therapies.

Inspired to be part of this wonderful journey ? Interested in joining an innovative, scientifically driven and fast paced team ? Want to contribute to a growing structure where your involvement will be valued ?

Contact us !

Open positions

 

Domain Therapeutics recherche un.e
technicien.ne de recherche en biologie Cellulaire (H/F)

la principale mission sera d’assurer le bon déroulement des différents tests menés au sein du département de biologie dans le respect de la réglementation (Bonnes Pratiques de Laboratoire) et des procédures internes. Notre Technicien.ne de recherche contribuera ainsi au succès de la Société en participant à la caractérisation de l’activité des candidats médicaments synthétisés par le département de chimie.
Les techniques utilisées seront : la culture cellulaire, la transfection cellulaire, la mesure de l’activité pharmacologique des candidats médicaments à l’aide des technologies de luminescence, fluorescence, BRET, FRET.

→ Poste à pourvoir immédiatement
→ CDI
→ Temps plein basé à Strasbourg
→ Salaire à définir + nombreux avantages

Domain Therapeutics vous offre une opportunité de mettre à profit vos compétences dans un cadre de travail humain et bienveillant… Tenté(e) ? alors n’hésitez plus, envoyez CV et lettre de motivation ici et rejoignez l’aventure Domain Therapeutics !

See the offer

 

Domain Therapeutics is opening a
Senior Scientist position in molecular pharmacology 

As a scientist specialized in molecular pharmacology, the senior scientist will join the Biology Department and take a role in the project team(s).
The senior scientist will work in close interaction with the Head of Biology Department and the CTO.

→ Available as soon as possible
→ Permanent contract
→ Full Time
→ Salary to be defined + numerous benefits

Domain Therapeutics offers you an opportunity to put your skills to good use in a humane and caring work environment… Tempted ? Then don’t hesitate any longer, Send your resume and your application here and join the Domain Therapeutics adventure !

See the offer

 

 

Domain Therapeutics is opening a principal Scientist Immuno-Oncology position

 The Senior Scientist specialised in Immunology/Immuno-Oncology  will take a principal role in supporting the implementation of the novel immune-oncology translational technologic platform and projects. This position requires a high experience in cytometry and immune-assays knowledge. It is a high impact and visible role.

→ Available as soon as possible
→ Permanent contract
→ Full Time
→ Salary to be defined + numerous benefits

Domain Therapeutics offers you an opportunity to put your skills to good use in a humane and caring work environment… Tempted ? Then don’t hesitate any longer, Send your resume and your application here and join the Domain Therapeutics adventure !

See the offer

 

Domain Therapeutics is opening an Early Development Program Lead position.

The early development program leader is responsible  for driving one of the company’s lead programs from development candidate stage to phase I/II proof of concept. This position requires both strategic thinking and operational excellence. It is a high impact and highly visible role. 

Available as soon as possible
Permanent contract
→ Full Time
Salary to be defined + numerous benefits

Domain Therapeutics offers you an opportunity to put your skills to good use in a humane and caring work environment… Tempted ? Then don’t hesitate any longer, Send your resume and your application here and join the Domain Therapeutics adventure !

See the offer

 

 

Domain Therapeutics is looking for post-doctoral researchers, to co-apply for a Marie Sklodowska-Curie Fellowship.

The position will only be open upon obtention of the European grant. For a successful application, you have to fit the eligibility criteria requested by the European Union.

→ August 15, 2020 : deadline for candidate application at Domain Therapeutics
→ September 9, 2020 : deadline for the grant co-application
→ March 2021 : estimated starting date of the project

 

    • Implementation of a novel proprietary technology for in-vivo and in-vitro target and drugs validation
      (ref: MSCA-DT01)
      See the offer

 

    • Development of biomarkers for target engagement and efficacy using an ex-vivo pharmacology approach
      (ref: MSCA-DT02)
      See the offer

 

    • Characterization of tumour-infiltrated lymphocytes (TILs) and immunosuppressive myeloid cells (gMDSCs and mMDSCs) from human tumours
      (ref: MSCA-DT03)
      See the offer

 

    • Characterization of therapeutic antibodies on human and mouse GPCRs 
      (ref: MSCA-DT04)
      See the offer

 

    • Development of novel BRET biosensors targeting immune-checkpoints
      (ref: MSCA-DT05)
      See the offer

 

    • Novel animal models validation of chemotherapy-related neuropathies
      (ref: MSCA-DT06)
      See the offer

 

    • Design and synthesis of a novel smart drug-like small molecule library.   
      (ref: MSCA-DT07)
      See the offer
Programs
Programs